Susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from patients with community-acquired pneumonia

被引:0
|
作者
Roblin, PM
Sokolovskaya, N
Hammerschlag, MR
机构
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:322 / 325
页数:4
相关论文
共 50 条
  • [21] Azithromycin in the treatment of community-acquired pneumonia
    Golec, K
    RzeszutkoGrabowska, M
    BukowskaNierojewska, D
    EXPANDING INDICATIONS FOR THE NEW MACROLIDES, AZALIDES, AND STREPTOGRAMINS, 1997, 21 : 626 - 628
  • [22] Role of Chlamydia pneumoniae in community-acquired pneumonia in hospitalized Jordanian adults
    Al-Aydie, Suzan N.
    Obeidat, Nathir M.
    Al-Younes, Hesham M.
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2016, 10 (03): : 227 - 236
  • [23] Prevalence of Chlamydia pneumoniae infection in Thai children with community-acquired pneumonia
    Likitnukul, S
    Nunthapisud, P
    Prapphal, N
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (08) : 749 - 750
  • [24] Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia in Istanbul, Turkey
    Somer, Ayper
    Salman, Nuran
    Yalcin, Isik
    Agacfidan, Ali
    JOURNAL OF TROPICAL PEDIATRICS, 2006, 52 (03) : 173 - 178
  • [25] SEVERE MIXED COMMUNITY-ACQUIRED PNEUMONIA WITH STREPTOCOCCUS-PNEUMONIAE AND CHLAMYDIA-PNEUMONIAE
    RASCHILAS, F
    DONETTI, L
    HILPERT, F
    MANET, P
    FOUET, P
    MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 (11): : 1161 - 1164
  • [26] SUSCEPTIBILITIES TO CLARITHROMYCIN AND ERYTHROMYCIN OF ISOLATES OF CHLAMYDIA-PNEUMONIAE FROM CHILDREN WITH PNEUMONIA
    ROBLIN, PM
    MONTALBAN, G
    HAMMERSCHLAG, MR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (07) : 1588 - 1589
  • [27] Efflux of novel quinolones in contemporary Streptococcus pneumoniae isolates from community-acquired pneumonia
    Lismond, Ann
    Carbonnelle, Sylviane
    Tulkens, Paul M.
    Van Bambeke, Francoise
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (04) : 948 - 951
  • [28] Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae
    Hammerschlag, MR
    Roblin, PM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (05) : 1409 - 1409
  • [29] Clinical characteristics of Chlamydia pneumoniae infection as the sole cause of community-acquired pneumonia
    File, TM
    Plouffe, JF
    Breiman, RF
    Skelton, SK
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) : 426 - 428
  • [30] Mycoplasma pneumoniae and community-acquired pneumonia
    Dey, AB
    Chaudhry, R
    Kumar, P
    Nisar, N
    Nagarkar, KM
    NATIONAL MEDICAL JOURNAL OF INDIA, 2000, 13 (02): : 66 - 70